AVR anteris technologies global corp.

Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-140

  1. 1,142 Posts.
    lightbulb Created with Sketch. 1
    As far as I can tell AHZ is now a research and development company that just sold the rights to its premiere IP outright with a small royalty. If the company could dump the majority of its staff and focus on IP generation for a few years this would be fine. But it can’t, it still has to manufacture these patches. So the entire manufacturing staff is being kept on. No idea whAt that equates to per year, but the cash burn on this company is prodigious and always has been. And also it’s major problem.

    this has still not been solved. Now is time for
    another code red that actually trims the fat this time.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.29
Change
-0.010(0.19%)
Mkt cap ! $82.01M
Open High Low Value Volume
$5.40 $5.40 $5.20 $69.34K 13.17K

Buyers (Bids)

No. Vol. Price($)
1 100 $5.15
 

Sellers (Offers)

Price($) Vol. No.
$5.35 84 1
View Market Depth
Last trade - 15.55pm 11/07/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.